---
figid: PMC6186432__nihms-986900-f0003
figtitle: Apoptotic membrane blebbing through DR5/Casp-3/ROCK1 signaling pathway
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
- Escherichia coli str. K-12 substr. MG1655
pmcid: PMC6186432
filename: nihms-986900-f0003.jpg
figlink: /pmc/articles/PMC6186432/figure/F2/
number: F2
caption: Apoptotic membrane blebbing through DR5/Casp-3/ROCK1 signaling pathway. Genes
  associated with response to treatment with nab-PAC and TIG are highlighted in orange.
papertitle: 'TBCRC 019: An open label, randomized, phase II trial of nanoparticle
  albumin-bound paclitaxel (nab-PAC or AbraxaneÂ®) with or without the anti-death receptor
  5 (DR5) monoclonal antibody tigatuzumab in patients with metastatic triple negative
  breast cancer.'
reftext: Andres Forero-Torres, et al. Clin Cancer Res. 2015 Jun 15;21(12):2722-2729.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9177384
figid_alias: PMC6186432__F2
figtype: Figure
redirect_from: /figures/PMC6186432__F2
ndex: a0e7f1e5-df0f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6186432__nihms-986900-f0003.html
  '@type': Dataset
  description: Apoptotic membrane blebbing through DR5/Casp-3/ROCK1 signaling pathway.
    Genes associated with response to treatment with nab-PAC and TIG are highlighted
    in orange.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF10B
  - FADD
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - ROCK1
  - ROCK2
  - MLC1
  - LIMK2
  - MYLK
  - CFL1
  - CFL2
  - DSTN
  - ACTA1
  - ACTA2
  - ACTB
  - ACTC1
  - ACTG1
  - ACTG2
  - fadd
  - limk2
  - mylka
  - acta2
  - tig
  - fadD
  - mlc
---
